About The Endocannabinoid System (ECS)
- Abnormalities in neuroendocrine stress response in psychosis- the role of endocannabinoids
- Agonistic Properties of Cannabidiol at 5-HT1a Receptors
- Anandamide and 2-arachidonoylglycerol- pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids
- Antiangiogenic activity of the endocannabinoid anandamide- Correlation to its tumor-suppressor efficacy
- An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors
- Biphasic Effects of Cannabinoids on Acetylcholine Release in the Hippocampus- Site and Mechanism of Action
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- Cannabinoid system and cyclooxygenases inhibitors
- Cannabis and endocannabinoid modulators- Therapeutic promises and challenges
- Cannabis, a complex plant- different compounds and different effects on individuals
- Care and Feeding of the Endocannabinoid System- A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System
- Clinical Endocannabinoid Deficiency (CECD)- Can this Concept Explain Therapeutic Benefits of Cannabis in Migraine, Fibromyalgia, Irritable Bowel Syndrome and other Treatment-Resistant Conditions
- Clinical Endocannabinoid Deficiency (CECD)- Can this Concept Explain Therapeutic Benefits of Cannabis in Migraine, Fibromyalgia, Irritable Bowel Syndrome and other Treatment-Resistant Conditions
- Clinical Endocannabinoid Deficiency Reconsidered- Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes
- Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol
- Endocannabinoid binding to the cannabinoid receptors- what is known and what remains unknown
- Endocannabinoids and the haematological system
- Endocannabinoid CB1 receptor-mediated rises in Ca2+ and depolarization-induced suppression of inhibition
- Endocannabinoid signalling and the deteriorating brain
- The endocannabinoid system- a new target for the regulation of energy balance and metabolism
- Endocannabinoid Signaling Regulates Sleep Stability
- Endocannabinoids and energy homeostasis- An update
- Endocannabinoid System in First Trimester Placenta- Low FAAH and High CB1 Expression Characterize Spontaneous Miscarriage
- Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol
- Enhanced discriminative stimulus effects of 9-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys
- Estrogen Receptor Beta and 2-arachidonoylglycerol Mediate the Suppressive Effects of Estradiol on Frequency of Postsynaptic Currents
- Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity
- Evidence that the plant cannabinoid cannabigerol is a highly potent a2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist
- Fatty Acid Binding Proteins (FABPs) are Intracellular Carriers for D9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
- Hardwiring the Brain- Endocannabinoids Shape Neuronal Connectivity
- Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes
- Mitochondria- a possible nexus for the regulation of energy homeostasis by the endocannabinoid system
- Modulating the endocannabinoid system in human health and disease- successes and failures
- Neuropharmacology of the Endocannabinoid Signaling System-Molecular Mechanisms, Biological Actions and Synaptic Plasticity
- Recent advances in cannabinoid receptor agonists and antagonists
- Relationships between eicosanoids and cannabinoids- Are eicosanoids cannabimimetic agents-
- Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes
- Role of the Endocannabinoid System in the Neuroendocrine Responses to Inflammation
- Targeting the endocannabinoid system with cannabinoid receptor agonists- pharmacological strategies and therapeutic possibilities
- The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids- Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
- The Endocannabinoid-CB Receptor System- Importance for development and in pediatric disease
- The endocannabinoid system and migraine
- The Endocannabinoid System as an Emerging Target of Pharmacotherapy
- The Endocannabinoid System, Cannabinoids, and Pain
- The endocannabinoid system drives neural progenitor proliferation
- The endocannabinoid system in normal and pathological brain ageing
- The endogenous cannabinoid system and its role in nociceptive behavior
- The orphan receptor GPR55 is a novel cannabinoid receptor
- The therapeutic potential of novel cannabinoid receptors
This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of issues of significance. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.